FR2453639B1 - - Google Patents

Info

Publication number
FR2453639B1
FR2453639B1 FR7908937A FR7908937A FR2453639B1 FR 2453639 B1 FR2453639 B1 FR 2453639B1 FR 7908937 A FR7908937 A FR 7908937A FR 7908937 A FR7908937 A FR 7908937A FR 2453639 B1 FR2453639 B1 FR 2453639B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7908937A
Other languages
French (fr)
Other versions
FR2453639A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR7908937A priority Critical patent/FR2453639A1/fr
Priority to IL59765A priority patent/IL59765A/xx
Priority to IT67532/80A priority patent/IT1130110B/it
Priority to GB8011487A priority patent/GB2047096B/en
Priority to ES490877A priority patent/ES490877A0/es
Priority to BE0/200164A priority patent/BE882706A/fr
Publication of FR2453639A1 publication Critical patent/FR2453639A1/fr
Application granted granted Critical
Publication of FR2453639B1 publication Critical patent/FR2453639B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7908937A 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl Granted FR2453639A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7908937A FR2453639A1 (fr) 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
IL59765A IL59765A (en) 1979-04-09 1980-04-03 Pharmaceutical preparation on the basis of naftidrofuryl which is release controlled
IT67532/80A IT1130110B (it) 1979-04-09 1980-04-04 Composizione medicamentosa a liberazione programmata immediata ritardo a base di naftidrofurile
GB8011487A GB2047096B (en) 1979-04-09 1980-04-08 Naftidrofuryl composition for immediate and delayed release
ES490877A ES490877A0 (es) 1979-04-09 1980-04-09 Procedimiento para la fabricacion de portadores medicamento-sos programados
BE0/200164A BE882706A (fr) 1979-04-09 1980-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7908937A FR2453639A1 (fr) 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl

Publications (2)

Publication Number Publication Date
FR2453639A1 FR2453639A1 (fr) 1980-11-07
FR2453639B1 true FR2453639B1 (es) 1982-03-19

Family

ID=9224133

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7908937A Granted FR2453639A1 (fr) 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl

Country Status (6)

Country Link
BE (1) BE882706A (es)
ES (1) ES490877A0 (es)
FR (1) FR2453639A1 (es)
GB (1) GB2047096B (es)
IL (1) IL59765A (es)
IT (1) IT1130110B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPH09500645A (ja) * 1993-07-22 1997-01-21 ワーナー−ランバート・コンパニー 制御放出タクリン薬物送達システムおよびその製造方法
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
MX356727B (es) * 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139713A (en) * 1976-05-13 1977-11-21 Shionogi & Co Ltd Sustained release cefalexin preparations
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication

Also Published As

Publication number Publication date
IT8067532A0 (it) 1980-04-04
IL59765A (en) 1983-12-30
ES8100881A1 (es) 1980-12-01
GB2047096B (en) 1983-08-24
ES490877A0 (es) 1980-12-01
BE882706A (fr) 1980-07-31
FR2453639A1 (fr) 1980-11-07
GB2047096A (en) 1980-11-26
IT1130110B (it) 1986-06-11
IL59765A0 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
CH655552B (es)
FR2445688B1 (es)
BR8002583A (es)
BR8006808A (es)
FR2449187B1 (es)
FR2447903B1 (es)
FR2453639B1 (es)
FR2448194B1 (es)
FR2446152B1 (es)
DE2940329C2 (es)
FR2447724B1 (es)
AT364253B (es)
AU79558S (es)
DE7926293U (es)
AU78390S (es)
AU78391S (es)
BR5901094U (es)
AU77669S (es)
AU80228S (es)
AU78569S (es)
AU77763S (es)
AU79200S (es)
AU78389S (es)
AU79557S (es)
AU79950S (es)

Legal Events

Date Code Title Description
TP Transmission of property